CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the road (Q38164792)

30 August 2017

title

CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the road (English)

1 reference

30 August 2017

2

David L Porter

1 reference

30 August 2017

Saar Gill

1

1 reference

30 August 2017

language of work or name

English

0 references

publication date

21 November 2013

1 reference

Expert Opinion on Biological Therapy

30 August 2017

published in

1 reference

30 August 2017

volume

14

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

37-49

1 reference

A decade of progress in lymphoma: advances and continuing challenges

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Update on therapy of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

CD19: a promising B cell target for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

CD19: a biomarker for B cell development, lymphoma diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Role of the CD19 and CD21/35 receptor complex in innate immunity, host defense and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

CD19 expression and growth inhibition of tumours in human multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

CD19 function in central and peripheral B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

An antibody-deficiency syndrome due to mutations in the CD19 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Phase I multidose-escalation study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered by intravenous infusion every 3 weeks to patients with relapsed/refractory B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Cell transfer immunotherapy for metastatic solid cancer--what clinicians need to know.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Reduced-intensity hematopoietic stem cell transplants for malignancies: harnessing the graft-versus-tumor effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

The immune contexture in human tumours: impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Effector and memory T-cell differentiation: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

A human memory T cell subset with stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Adoptive immunotherapy for cancer: harnessing the T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Adoptive T cell therapy for cancer in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

Inducible apoptosis as a safety switch for adoptive cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.860442

10.1517/14712598.2014.860442

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference